Last updated: August 27, 2025
Sponsor: University of Washington
Overall Status: Completed
Phase
4
Condition
Contraception
Hiv Infections
Treatment
PrEP
Clinical Study ID
NCT04666792
STUDY00009583
R01MH123267
Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female of reproductive age
Sexually active
Able and willing to provide informed consent
HIV negative, according to national HIV testing algorithm
Has at least one risk factor for HIV as defined by the Kenya National AIDS and STIControl Program
Exclusion
Exclusion Criteria:
- Otherwise not eligible based on the above inclusion criteria
Study Design
Total Participants: 25457
Treatment Group(s): 1
Primary Treatment: PrEP
Phase: 4
Study Start date:
March 01, 2021
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Kenyatta National Hospital
Kisumu,
KenyaSite Not Available
Kenyatta National Hospital
Kisumu 191245,
KenyaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.